METTL3 and urinary bladder cancer: Further investigation revealed that METTL3/miR-146a-5p/NUMB/NOTCH2 signaling was positively correlated with recurrence, metastasis, and survival in bladder cancer patients, indicating that MLT sheds new light on therapeutic targets for recurrent bladder cancer treatment.